An open-label, single-arm, multicenter, observational, real world study evaluating the effectiveness of all oral ixazomib-based regimen in Chinese Patients with Multiple Myeloma
Latest Information Update: 07 Aug 2021
At a glance
- Drugs Ixazomib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms Modify Study
- 07 Aug 2021 New trial record
- 17 Jun 2021 Trial design has been presented at the 26th Congress of the European Haematology Association